<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01233986</url>
  </required_header>
  <id_info>
    <org_study_id>ABYSS</org_study_id>
    <nct_id>NCT01233986</nct_id>
  </id_info>
  <brief_title>Association of Apolipoprotein B-48 Level and Large arterY Atherosclerotic iSchemic Stroke(ABYSS)</brief_title>
  <official_title>Prospective, Matched Case Control, Multicenter, Observational Study for the Association of Serum Apolipoprotein B-48 Level and Large arterY Atherosclerotic iSchemic Stroke(ABYSS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether the serum apoB48 level is associated with
      atherosclerotic ischemic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The serum level of fasting apolipoprotein B-48</measure>
    <time_frame>72 hours within stroke onset</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The serum level of postprandial apolipoprotein B-48</measure>
    <time_frame>within 72 hours after stroke onset</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The serum level of the postprandial triglyceride</measure>
    <time_frame>72 hours within stroke onset</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The serum level of fasting total cholesterol</measure>
    <time_frame>within 72 hours after stroke onset</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The serum level of fasting LDL cholesterol</measure>
    <time_frame>within 72 hours after stroke onset</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the level of fasting HDL cholesterol</measure>
    <time_frame>within 72 hours after stroke onset</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the level of fasting triglyceride</measure>
    <time_frame>within 72 hours after stroke onset</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Case group - Large artery atherosclerosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group-Small vessel occlusion</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum level of apolipoprotein B-48
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Tertiary Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Large artery atherosclerotic ischemic stroke group(LAA group)

          -  Age over 20 years

          -  Patients with symptomatic stenosis in the eligible vessels(the middle cerebral artery,
             anterior cerebral artery, or internal carotid artery) as assessed by MRA or CTA
             corresponding to the acute ischemic stroke

          -  Patients without the occlusion of corresponding artery by MRA or CTA

          -  The fasting and postprandial serum Apo B-48 level can be assessed within 72 hours
             after the symptom onset of ischemic stroke

        Small vessel occlusive ischemic stroke group (SVO group)

          -  Age over 20 years

          -  Patients with acute ischemic stroke of basal ganglia, internal capsule, or corona
             radiata

          -  Patients without both symptomatic and asymptomatic arterial occlusion or stenosis by
             MRA or CTA

          -  Patients without a history of systemic atherosclerosis(for example, acute myocardial
             infarction, angina, peripheral arterial disease, aortic aneurysm)

          -  The fasting and postprandial serum Apo B-48 level can be assessed within 72 hours
             after the symptom onset of ischemic stroke

        Exclusion Criteria: both LAA group and SVO group

          -  Patients with cardioembolic ischemic stroke

          -  Patients treated with lipid lowering agents or steroid within the previous 30 dsys

          -  Patients with severe liver disease (AST &gt;100 or ALT &gt;100) at the time of randomization

          -  Patients with endocrine disease except diabetes mellitus at the time of randomization
             (for example, thyroid disease, adrenal disease)

          -  Patients with severe renal disease (serum creatinine &gt;2.0mg/dl)at the time of
             randomization

          -  chronic alcoholics or drug user

          -  Patients with infection at the time of randomization

          -  Patients, in the opinion of the investigator, unlikely to comply with the clinical
             study or unsuitable for the any other disease or reason

          -  Informed consent has not been obtained
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Byung-Chul Lee, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Byung-Chul Lee, MD, PhD</last_name>
    <phone>+82-31-380-3741</phone>
    <email>ssbrain@hallym.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kyung-Ho Yu, MD, PhD</last_name>
    <phone>+82-31-380-3743</phone>
    <email>ykh1030@hallym.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byung-chul Lee, MD,PhD</last_name>
      <phone>+82-31-380-3741</phone>
      <email>ssbrain@hallym.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Kyung-Ho Yu, MD, PhD</last_name>
      <phone>+82-31-380-3743</phone>
      <email>ykh1030@hallym.ac.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Mi Sun Oh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2010</study_first_submitted>
  <study_first_submitted_qc>November 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <last_update_submitted>October 4, 2011</last_update_submitted>
  <last_update_submitted_qc>October 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Ischemic Stroke</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Apolipoprotein B48</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

